Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
The GMZ2 malaria vaccine: from concept to efficacy in humans
Michael Theisen, Bright Adu, Benjamin Mordmüller, Subhash Singh
33
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The GMZ2 malaria vaccine: from concept to efficacy in humans'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
100%
Antibodies
100%
Preclinical Study
100%
Plasmodium falciparum
100%
Antimalarial Agent
100%
Aluminum Hydroxide
100%
Malaria Vaccine
100%
Recombinant Protein
100%
Platyrrhini
100%
Subunit Vaccine
100%
Immunology and Microbiology
Monospecific Antibody
100%
Adaptive Immune System
100%
Vaccine Efficacy
100%
Medline
100%
Plasmodium falciparum
100%
Platyrrhini
100%
Subunit Vaccine
100%
Antimalarial Agent
100%
Preclinical Study
100%
Keyphrases
Malaria Vaccine
100%
GMZ2
100%
PubMed
28%
Immunogenic
28%
Alum
28%
Clinical Development
14%
Rodents
14%
Epidemiological Study
14%
Specific Antibodies
14%
Phase II Trial
14%
In Vitro Study
14%
Area Cover
14%
Recombinant Protein
14%
Plasmodium Falciparum
14%
Functional Activity
14%
Eastern Africa
14%
New World Monkeys
14%
Subunit Vaccine
14%
Conserved Domain
14%
Sequence Diversity
14%
Malaria-endemic Countries
14%
MSP3
14%
Adjuvanted
14%
Glurp
14%
Asexual Blood Stages
14%
Alhydrogel
14%
Phase 1 Study
14%
Expert Commentary
14%
Naturally Acquired Immunity
14%
Antibody Sequence
14%
Ncbi
14%
West Central Africa
14%